|
||||||||||
Home > Beauty & Fashion Articles L'Oreal Paris Presents 'A Night of Hope' to Benefit Ovarian Cancer Research
NEW YORK, Nov. 7 /PRNewswire/ -- Diane Keaton, Andie MacDowell, President of L'Oreal Paris Carol J. Hamilton and Harper's Bazaar Editor-in-Chief Glenda Bailey will co-host "A Night of Hope" to benefit The Ovarian Cancer Research Fund (OCRF) on Wednesday, November 7th at Murano from 6:30 - 9:30 PM in Los Angeles, CA. They will be joined by other L'Oreal spokespeople including Eva Longoria, Kerry Washington, and Dayle Haddon. The evening will include a cocktail reception and luxury silent auction, which will feature exceptional photography and fashions and accessories from designers including Chanel, Louis Vuitton, Donna Karan, Bulgari and De Beers. "A Night of Hope" is hosted by L'Oreal Paris and all proceeds raised at the event will be donated to OCRF's research programs. President of L'Oreal Paris, Carol J. Hamilton says, "This year marks the tenth anniversary of L'Oreal Paris' support of The Ovarian Cancer Research Fund. I am proud of the fact that L'Oreal is the largest corporate fundraiser in this critical fight against ovarian cancer. Since 1997, we have helped to raise over $13 million to fund life-saving research and to promote awareness building programs to help empower women to make educated choices about their health and well-being." Additionally, L'Oreal has created programs to promote ovarian cancer awareness, which include the first-ever public service announcements for ovarian cancer featuring L'Oreal spokespeople Andie MacDowell and Milla Jovovich. L'Oreal has also created the signature "Color of Hope" cosmetics and jewelry collections that raise funds for OCRF. This year L'Oreal has added a sterling silver pendant and earrings to the jewelry collection. All of the jewelry items are available for purchase online at http://www.lorealcolorofhope.com. A special diamond Color of Hope necklace has been created to commemorate this star-studded event. "Awareness is a key element in winning the fight against ovarian cancer. There is currently no effective, easy to use method of early detection for ovarian cancer and as a result, many of the cases are diagnosed too late. In addition to raising much needed funds for research programs, L'Oreal has been extremely instrumental in spreading the message that every woman should have knowledge of this disease and its symptoms," explains Elizabeth Howard, CEO of OCRF. ABOUT L'OREAL PARIS L'Oreal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oreal Paris made a long-term commitment to The Ovarian Cancer Research Fund (OCRF), which continues to build. To date, L'Oreal Paris has helped raise over $13 million dollars on behalf of OCRF with fundraising efforts such as the L'Oreal Legends Gala and L'Oreal's annual "Color of Hope" bracelet and cosmetic collection. The L'Oreal Paris Brand Division of L'Oreal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L'Oreal Paris product family includes Preference, Excellence, Natural Match, Feria, and Couleur Experte haircolors; VIVE Pro, Studio Line, and L'Oreal Kids hair care; Dermo-Expertise skin care, including Skin Genesis; Advanced Revitalift, Wrinkle De-Crease, Age Perfect, Men's Expert, Sublime Slim and Sublime Bronze; and L'Oreal Paris Cosmetics, including Colour Riche Lipcolours, Infallible Never Fail Lipcolour, True Match Makeup, Wear Infinite Eyeshadows, Voluminous, Double Extend, Telescopic, and Volume Shocking mascaras, among many others, and the HIP High Intensity Pigments line. ABOUT THE OVARIAN CANCER RESEARCH FUND The Ovarian Cancer Research Fund (OCRF) is the leading independent, non-profit organization in the United States dedicated to advancing research, raising awareness and finding a cure for ovarian cancer. Ovarian cancer takes the lives of over 15,000 women in the United States each year, with over 20,000 new cases being diagnosed annually. There is currently no method of early detection, leading to late diagnosis in 75 percent of all cases. OCRF is committed to funding the best and the brightest of scientific investigators whose work focuses on new tools for detection and better treatment options. To date, OCRF has funded researchers at 40 leading cancer centers nationwide. For more information, go to http://www.ocrf.org. Related Articles
See all Look-Your-Best Articles
Search: |
| |
||||||||
Copyright © 2005-2012 Sostre & Associates |
||||||||||